FDA Adverse Event Malfunction Summary report: N

SYNCHROMED II

MDR report key: 3170946 · Received June 14, 2013

Report

Report Number
3004209178-2013-10407
Event Type
Malfunction
Date Received
June 14, 2013
Date of Event
February 14, 2013
Report Date
November 30, 2016
Manufacturer
MDT PUERTO RICO OPERATIONS CO
Product Code
LKK
PMA / PMN Number
P860004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT PRODUCTS: PRODUCT ID 8709, SERIAL# (B)(4), IMPLANTED: (B)(6) 2007, PRODUCT TYPE CATHETER; PRODUCT ID 8840, SERIAL# UNKNOWN, PRODUCT TYPE PROGRAMMER, PHYSICIAN. (B)(4).

Additional Manufacturer Narrative · 1

THE PREVIOUSLY REPORTED EVAL CODE-CONCLUSIONS WERE UPDATED TO (B)(4). A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

A REPRESENTATIVE REPORTED THAT, AT THE PATIENT¿S LAST REFILL ON (B)(6) 2013, THE CONCENTRATION WAS CHANGED, ¿BUT THAT CONCENTRATION WOULD NOT CHANGE IN THE ACTUAL PROGRAMMER¿. THE REPRESENTATIVE CONFIRMED THAT THEY DID NOT CHANGE THE PROGRAMMED CONCENTRATION, AND A BRIDGE BOLUS WAS NOT PERFORMED. THE MEDICATION USED WITHIN THE SYSTEM WAS CHANGED FROM 10 MG/ML TO 15 MG/ML. FURTHER DISCUSSION REVEALED THE PATIENT WAS RECEIVING 2.64 MG/DAY INSTEAD OF 1.76 MG/DAY. THE PATIENT WAS NOTED TO BE ¿TOTALLY ASYMPTOMATIC AND DOING WELL¿. THE PATIENT WAS NOTED TO HAVE BEEN ON FLEX DOSING, AND THE REPRESENTATIVE INDICATED THEY WOULD SPEAK TO THE PHYSICIAN TO SEE HOW THE EXTRA 0.88 MG/ML WOULD BE DISTRIBUTED IN THE FLEX DOSING. THE PATIENT WAS HAVING A REFILL ON THE DAY OF THE REPORT. THE MEDICATION USED WITHIN THE SYSTEM WAS MORPHINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
271800 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MDT PUERTO RICO OPERATIONS CO 863720

Patients

Seq Age Sex Outcome Treatment
1 00076 YR